Haemonetics - Crunchbase Company Profile & Funding

Q: When was the last funding round for Haemonetics?

Haemonetics closed its last funding round on obfuscated from a Post-IPO Debt round.

Q: How much funding has Haemonetics raised to date?

Haemonetics has raised obfuscated.

Overview

Haemonetics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Haemonetics

CB Rank

44219

Haemonetics is a global medical technology company that provides Blood Management and Interventional Technologies.

Founded

obfuscation

Public

Post-IPO Debt

Boston, Massachusetts, United States

1001-5000

www.haemonetics.com

Biotechnology

Consulting

Health Care

Medical

Medical Device

Funding Rounds

Post-IPO Debt

OBF

obfuscation

Post-IPO Equity

OBF

obfuscation

Post-IPO Equity

OBF

obfuscation

Key People

Michelle Basil: Executive Vice President, General Counsel
Juan Diaz Cartelle: Executive Medical Director

Details

Legal Name

Haemonetics Corporation

Operating Status

Active

Number of Exits

obfuscation

Stock Symbol

NYSE:HAE

Company Type

For Profit

Founders

Jack Latham

About the Company

Haemonetics specializes in blood processing technology.

Phone Number

7813487738

Contact Email

CustomerServiceNA@Haemonetics.com

Predictions & Insights

Growth Insight

See this Growth Insight

Haemonetics is

Lorem

to be growing

Top Contributing Factors

Financial Growth

Products & Services

Hospital Solutions

Medical technology solutions designed to enhance clinical outcomes and procedural effectiveness in hospitals.

Plasma Center Technologies

Technologies that enable higher plasma yield collections and improve productivity and quality in plasma donation centers.

Research & Development

Haemonetics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Debt - Haemonetics	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Haemonetics	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Haemonetics	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Haemonetics	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Haemonetics	—	obfuscated obfuscation	—	Post-IPO Debt

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Debt - Haemonetics	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Haemonetics	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Haemonetics	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Haemonetics	—	obfuscated obfuscation	—	Post-IPO Debt
obfuscated obfuscation	Post-IPO Debt - Haemonetics	—	obfuscated obfuscation	—	Post-IPO Debt

Investors

Investments

Investment Breakdown

Number of Investments

Number of Exits

obfuscation

Number of Acquisitions

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Vivasure Medical	Yes	Series D - Vivasure Medical	obfuscated obfuscation
obfuscated obfuscation	Vivasure Medical	Yes	Series D - Vivasure Medical	obfuscated obfuscation
obfuscated obfuscation	Vivasure Medical	Yes	Series D - Vivasure Medical	obfuscated obfuscation
obfuscated obfuscation	Vivasure Medical	Yes	Series D - Vivasure Medical	obfuscated obfuscation
obfuscated obfuscation	Vivasure Medical	Yes	Series D - Vivasure Medical	obfuscated obfuscation

Investment Breakdown

Number of Investments

Number of Exits

obfuscation

Number of Acquisitions

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Vivasure Medical	Yes	Series D - Vivasure Medical	obfuscated obfuscation
obfuscated obfuscation	Vivasure Medical	Yes	Series D - Vivasure Medical	obfuscated obfuscation
obfuscated obfuscation	Vivasure Medical	Yes	Series D - Vivasure Medical	obfuscated obfuscation
obfuscated obfuscation	Vivasure Medical	Yes	Series D - Vivasure Medical	obfuscated obfuscation
obfuscated obfuscation	Vivasure Medical	Yes	Series D - Vivasure Medical	obfuscated obfuscation